Luye Pharma Group Ltd banner

Luye Pharma Group Ltd
HKEX:2186

Watchlist Manager
Luye Pharma Group Ltd Logo
Luye Pharma Group Ltd
HKEX:2186
Watchlist
Price: 2.47 HKD 1.65%
Market Cap: HK$9.9B

Cash Flow Statement

Cash Flow Statement
Luye Pharma Group Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Net Income
76
82
88
94
90
96
92
93
86
88
87
85
66
64
66
70
83
96
119
145
166
192
218
224
195
181
159
161
201
211
217
349
1 116
1 329
1 473
1 663
1 634
1 455
942
746
(75)
(188)
670
523
700
1 001
839
767
Depreciation & Amortization
11
11
11
12
12
12
13
13
15
22
28
33
41
40
41
42
41
41
42
42
44
46
47
49
66
76
77
82
74
76
83
28
244
228
311
231
456
493
511
526
582
638
671
676
702
719
791
851
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
16
31
49
65
69
51
0
50
66
25
20
21
21
21
18
Other Non-Cash Items
5
4
3
3
0
(0)
(2)
(7)
(5)
(4)
2
9
12
14
12
13
(1)
(5)
(3)
(15)
(2)
0
(3)
11
(19)
(15)
(14)
(10)
19
24
30
(39)
(35)
(41)
84
183
202
335
371
356
661
666
455
416
399
450
429
525
Cash Taxes Paid
0
(0)
0
0
0
2
(1)
0
8
5
13
25
10
14
10
(4)
15
15
22
27
23
23
31
41
39
43
38
42
60
83
88
62
196
212
179
153
177
202
160
203
271
156
93
151
132
80
207
244
Cash Interest Paid
6
5
4
3
2
2
2
2
2
4
9
12
16
18
16
15
13
11
10
8
9
9
9
11
9
11
13
18
23
28
34
(1)
52
83
158
215
207
271
330
305
297
311
369
368
472
552
450
423
Change in Working Capital
(44)
(60)
(65)
(76)
(57)
(57)
(69)
(51)
(45)
(119)
(11)
0
18
90
21
10
(17)
56
(1)
(7)
(45)
(106)
(137)
(128)
12
9
49
55
31
(69)
(48)
(107)
(361)
(548)
(823)
(890)
(869)
(1 015)
(791)
(553)
(986)
(879)
(142)
123
(206)
(1 658)
(1 891)
204
Cash from Operating Activities
48
N/A
37
-23%
36
-2%
32
-12%
46
+42%
51
+11%
35
-31%
48
+38%
51
+6%
(13)
N/A
106
N/A
126
+19%
136
+8%
208
+53%
141
-32%
135
-4%
106
-22%
188
+78%
157
-17%
165
+5%
163
-1%
132
-19%
125
-5%
157
+25%
254
+62%
250
-2%
271
+8%
288
+6%
325
+13%
241
-26%
282
+17%
250
-12%
964
+286%
1 046
+9%
1 046
0%
1 332
+27%
1 423
+7%
1 268
-11%
1 033
-19%
1 075
+4%
182
-83%
238
+30%
1 654
+596%
1 739
+5%
1 595
-8%
511
-68%
168
-67%
2 347
+1 299%
Investing Cash Flow
Capital Expenditures
(12)
(14)
(20)
(27)
(29)
(27)
(17)
(15)
(9)
(67)
(15)
(12)
(15)
31
(32)
(36)
(44)
(57)
(57)
(60)
(25)
(30)
2
(29)
(141)
(142)
(257)
(287)
(338)
(356)
(325)
(131)
(625)
(2 470)
(2 485)
(860)
(3 051)
(3 258)
(1 520)
(1 579)
(1 542)
(1 389)
(1 164)
(1 066)
(1 165)
(1 400)
(1 708)
(1 580)
Other Items
(4)
(16)
(20)
(13)
(15)
(3)
324
324
(334)
(460)
(705)
(823)
(161)
(35)
(108)
29
41
40
14
(22)
(42)
(42)
8
(16)
(54)
(54)
(80)
(277)
(305)
(237)
(235)
(29)
(119)
(225)
(513)
(1 135)
422
2 564
1 658
439
(1 894)
(1 233)
(495)
(990)
(253)
(446)
237
347
Cash from Investing Activities
(15)
N/A
(30)
-95%
(40)
-35%
(40)
-1%
(45)
-11%
(29)
+35%
307
N/A
309
+1%
(343)
N/A
(527)
-53%
(720)
-37%
(835)
-16%
(176)
+79%
(4)
+98%
(140)
-3 477%
(6)
+95%
(4)
+43%
(17)
-364%
(43)
-156%
(82)
-90%
(66)
+19%
(71)
-8%
10
N/A
(45)
N/A
(194)
-330%
(195)
-1%
(337)
-72%
(565)
-68%
(643)
-14%
(593)
+8%
(560)
+6%
(161)
+71%
(744)
-363%
(2 695)
-262%
(2 998)
-11%
(1 994)
+33%
(2 629)
-32%
(694)
+74%
138
N/A
(1 140)
N/A
(3 436)
-201%
(2 623)
+24%
(1 658)
+37%
(2 056)
-24%
(1 418)
+31%
(1 846)
-30%
(1 471)
+20%
(1 233)
+16%
Financing Cash Flow
Net Issuance of Common Stock
104
0
0
0
0
0
0
36
320
0
0
572
(2)
0
0
(289)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(284)
(459)
(174)
(20)
(30)
(9)
(78)
(78)
1 044
1 044
0
0
923
923
0
230
592
Net Issuance of Debt
(68)
(72)
(64)
(52)
(49)
(27)
10
(22)
15
227
110
(45)
108
(129)
(66)
112
(112)
(64)
6
(1)
60
71
22
48
65
19
95
253
179
282
242
1 428
1 237
2 756
3 277
(1)
2 327
2 877
1 440
(19)
(406)
299
(666)
222
(478)
27
1 856
2 327
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(213)
(362)
(290)
0
(377)
0
(175)
0
0
0
0
0
0
0
0
0
Other
10
0
(3)
(3)
(14)
0
(17)
(17)
(17)
0
(19)
(19)
(19)
0
(14)
(14)
(14)
0
0
0
0
0
0
0
0
0
0
0
(9)
0
0
(291)
167
(168)
(562)
340
(98)
(431)
(933)
138
1 241
674
720
387
397
272
871
(359)
Cash from Financing Activities
46
N/A
43
-6%
(67)
N/A
(55)
+17%
(63)
-15%
(41)
+35%
(7)
+83%
(3)
+54%
319
N/A
531
+67%
411
-23%
508
+24%
87
-83%
(150)
N/A
(83)
+45%
(192)
-131%
(127)
+34%
(79)
+38%
6
N/A
(1)
N/A
60
N/A
71
+19%
22
-69%
48
+118%
65
+35%
19
-71%
95
+405%
253
+165%
170
-33%
273
+61%
233
-14%
853
+266%
733
-14%
2 052
+180%
2 405
+17%
167
-93%
1 844
+1 002%
1 992
+8%
254
-87%
988
+289%
1 879
+90%
973
-48%
54
-94%
1 531
+2 728%
842
-45%
299
-64%
2 956
+889%
2 560
-13%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(42)
(85)
(42)
(45)
(36)
(8)
(76)
112
242
(52)
(158)
(164)
(114)
(104)
(98)
45
(76)
Net Change in Cash
79
N/A
50
-36%
(70)
N/A
(63)
+10%
(62)
+1%
(20)
+68%
335
N/A
354
+6%
26
-93%
(9)
N/A
(203)
-2 257%
(200)
+1%
47
N/A
54
+14%
(82)
N/A
(63)
+23%
(24)
+61%
93
N/A
120
+29%
83
-31%
157
+90%
132
-16%
157
+20%
160
+2%
125
-22%
74
-41%
29
-60%
(23)
N/A
(149)
-538%
(79)
+47%
(45)
+43%
900
N/A
868
-4%
362
-58%
407
+12%
(532)
N/A
630
N/A
2 489
+295%
1 538
-38%
1 166
-24%
(1 427)
N/A
(1 571)
-10%
(115)
+93%
1 100
N/A
915
-17%
(1 133)
N/A
1 698
N/A
3 597
+112%
Free Cash Flow
Free Cash Flow
37
N/A
24
-35%
17
-30%
5
-68%
16
+206%
24
+48%
18
-25%
33
+84%
42
+26%
(79)
N/A
90
N/A
115
+27%
122
+6%
239
+97%
109
-54%
100
-9%
62
-38%
131
+113%
100
-24%
105
+5%
139
+32%
102
-26%
128
+25%
128
+1%
114
-11%
108
-5%
14
-87%
1
-93%
(13)
N/A
(115)
-771%
(43)
+63%
118
N/A
339
+187%
(1 423)
N/A
(1 439)
-1%
472
N/A
(1 628)
N/A
(1 989)
-22%
(486)
+76%
(504)
-4%
(1 359)
-170%
(1 152)
+15%
490
N/A
673
+37%
430
-36%
(889)
N/A
(1 541)
-73%
766
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett